Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
AKBA | Akebia Therapeutics, Inc. | CEO and President, Director | $3.74M | -$209K | -5.3% | Feb 29, 2024 |
ZYNE | Zynerba Pharmaceuticals, Inc. | Director | Oct 10, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|